Clinical Trials Browser

Active not recruiting × Myelodysplastic Syndromes × ivosidenib × Clear all

NCT03503409 2025-05-18

IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome

Phase 2 Active not recruiting

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute